The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.
An algorithm based testing for Fatty Liver Disease
This is the 142nd ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
The AICVD tool can predict the risk of cardiovascular disease.
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
It is a two dose vaccine to be administered intramuscularly at 28 days apart
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
Subscribe To Our Newsletter & Stay Updated
